Clinical Trial Update: Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update assessing Envarsus XR's effect on kidney biopsy subclinical rejection and blood immunologic profile in end-stage renal disease; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Envarsus XR (Tacrolimus)

Snippet

Sponsor: Roberto Gedaly | Conditions: End Stage Renal Disease | Phase 2, Phase 3 | Status: RECRUITING